Which has preferable valuation and earnings, BDSX or ITGR?

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biodesix $88.50M 2.46 -$35.26M -$4.06 N/A Integer $1.85B 1.84 $102.81M $4.01 25.02

Is BDSX or ITGR more profitable?

Integer has a net margin of 7.64% compared to Biodesix's net margin of -33.26%. Integer's return on equity of 12.83% beat Biodesix's return on equity. Company Net Margins Return on Equity Return on Assets Biodesix -33.26% -2,101.40% -35.65% Integer 7.64% 12.83% 6.51%

Does the media refer more to BDSX or ITGR?

In the previous week, Integer had 7 more articles in the media than Biodesix. MarketBeat recorded 11 mentions for Integer and 4 mentions for Biodesix. Integer's average media sentiment score of 1.49 beat Biodesix's score of 0.92 indicating that Integer is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biodesix 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integer 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, ITGR or ELV?

Elevance Health has higher revenue and earnings than Integer. Elevance Health is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 1.84 $102.81M $4.01 25.02 Elevance Health $199.13B 0.42 $5.66B $22.50 17.14

Does the media prefer ITGR or ELV?

In the previous week, Elevance Health had 19 more articles in the media than Integer. MarketBeat recorded 30 mentions for Elevance Health and 11 mentions for Integer. Integer's average media sentiment score of 1.49 beat Elevance Health's score of 1.46 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Elevance Health 24 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to BAX or ITGR?

In the previous week, Baxter International had 1 more articles in the media than Integer. MarketBeat recorded 12 mentions for Baxter International and 11 mentions for Integer. Integer's average media sentiment score of 1.49 beat Baxter International's score of 0.69 indicating that Integer is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integer 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, PODD or ITGR?

Insulet has higher revenue and earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Insulet $2.71B 4.28 $247.10M $4.30 38.95 Integer $1.85B 1.84 $102.81M $4.01 25.02

Is PODD or ITGR more profitable?

Insulet has a net margin of 10.44% compared to Integer's net margin of 7.64%. Insulet's return on equity of 26.87% beat Integer's return on equity. Company Net Margins Return on Equity Return on Assets Insulet 10.44% 26.87% 12.01% Integer 7.64% 12.83% 6.51%

Does the media favor PODD or ITGR?

In the previous week, Insulet had 32 more articles in the media than Integer. MarketBeat recorded 43 mentions for Insulet and 11 mentions for Integer. Integer's average media sentiment score of 1.49 beat Insulet's score of 0.49 indicating that Integer is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Insulet 13 Very Positive mention(s) 1 Positive mention(s) 27 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Integer 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, ITGR or GMED?

Globus Medical has higher revenue and earnings than Integer. Globus Medical is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 1.84 $102.81M $4.01 25.02 Globus Medical $2.94B 3.72 $537.87M $4.30 18.72

Is ITGR or GMED more profitable?

Globus Medical has a net margin of 18.92% compared to Integer's net margin of 7.64%. Globus Medical's return on equity of 13.46% beat Integer's return on equity. Company Net Margins Return on Equity Return on Assets Integer 7.64% 12.83% 6.51% Globus Medical 18.92% 13.46% 11.65%

Does the media favor ITGR or GMED?

In the previous week, Integer and Integer both had 11 articles in the media. Integer's average media sentiment score of 1.49 beat Globus Medical's score of 1.42 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Globus Medical 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Integer (ITGR) Competitors

$100.32 +0.92 (+0.93%)

Closing price 07/28/2026 03:59 PM Eastern

Extended Trading

$99.18 -1.14 (-1.14%)

As of 07/28/2026 04:10 PM Eastern

Compare

ITGR vs. BDSX, ELV, BAX, PODD, and GMED

Should you buy Integer stock or one of its competitors? MarketBeat compares Integer with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Integer include Biodesix (BDSX), Elevance Health (ELV), Baxter International (BAX), Insulet (PODD), and Globus Medical (GMED). These companies are all part of the "medical" sector.

How does Integer compare to Biodesix?

Biodesix (NASDAQ:BDSX) and Integer (NYSE:ITGR) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

Biodesix has a beta of 0.53, indicating that its stock price is 47% less volatile than the broader market. Comparatively, Integer has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market.

In the previous week, Integer had 7 more articles in the media than Biodesix. MarketBeat recorded 11 mentions for Integer and 4 mentions for Biodesix. Integer's average media sentiment score of 1.49 beat Biodesix's score of 0.92 indicating that Integer is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biodesix	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Integer has a net margin of 7.64% compared to Biodesix's net margin of -33.26%. Integer's return on equity of 12.83% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biodesix	-33.26%	-2,101.40%	-35.65%
Integer	7.64%	12.83%	6.51%

Biodesix currently has a consensus target price of $28.33, suggesting a potential upside of 34.73%. Integer has a consensus target price of $97.00, suggesting a potential downside of 3.31%. Given Biodesix's stronger consensus rating and higher possible upside, equities research analysts clearly believe Biodesix is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biodesix	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.80
Integer	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54

21.0% of Biodesix shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 23.2% of Biodesix shares are owned by company insiders. Comparatively, 1.1% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biodesix	$88.50M	2.46	-$35.26M	-$4.06	N/A
Integer	$1.85B	1.84	$102.81M	$4.01	25.02

Summary

Integer beats Biodesix on 12 of the 16 factors compared between the two stocks.

How does Integer compare to Elevance Health?

Integer (NYSE:ITGR) and Elevance Health (NYSE:ELV) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, analyst recommendations and profitability.

Integer presently has a consensus target price of $97.00, indicating a potential downside of 3.31%. Elevance Health has a consensus target price of $440.90, indicating a potential upside of 14.32%. Given Elevance Health's stronger consensus rating and higher probable upside, analysts clearly believe Elevance Health is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54
Elevance Health	0 Sell rating(s)	8 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.65

Integer has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market.

Elevance Health has higher revenue and earnings than Integer. Elevance Health is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	1.84	$102.81M	$4.01	25.02
Elevance Health	$199.13B	0.42	$5.66B	$22.50	17.14

99.3% of Integer shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 1.1% of Integer shares are held by insiders. Comparatively, 0.3% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Elevance Health had 19 more articles in the media than Integer. MarketBeat recorded 30 mentions for Elevance Health and 11 mentions for Integer. Integer's average media sentiment score of 1.49 beat Elevance Health's score of 1.46 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Elevance Health	24 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Integer has a net margin of 7.64% compared to Elevance Health's net margin of 2.47%. Elevance Health's return on equity of 14.64% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	7.64%	12.83%	6.51%
Elevance Health	2.47%	14.64%	5.22%

Summary

Elevance Health beats Integer on 9 of the 17 factors compared between the two stocks.

How does Integer compare to Baxter International?

Baxter International (NYSE:BAX) and Integer (NYSE:ITGR) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, media sentiment, risk, analyst recommendations, profitability and institutional ownership.

Baxter International presently has a consensus price target of $21.09, suggesting a potential downside of 13.54%. Integer has a consensus price target of $97.00, suggesting a potential downside of 3.31%. Given Integer's stronger consensus rating and higher probable upside, analysts clearly believe Integer is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	4 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.85
Integer	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54

Integer has lower revenue, but higher earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.32B	1.11	-$957M	-$2.13	N/A
Integer	$1.85B	1.84	$102.81M	$4.01	25.02

Baxter International has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market. Comparatively, Integer has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market.

In the previous week, Baxter International had 1 more articles in the media than Integer. MarketBeat recorded 12 mentions for Baxter International and 11 mentions for Integer. Integer's average media sentiment score of 1.49 beat Baxter International's score of 0.69 indicating that Integer is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Integer has a net margin of 7.64% compared to Baxter International's net margin of -9.70%. Baxter International's return on equity of 16.15% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.70%	16.15%	5.24%
Integer	7.64%	12.83%	6.51%

90.2% of Baxter International shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 0.2% of Baxter International shares are owned by company insiders. Comparatively, 1.1% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Integer beats Baxter International on 14 of the 17 factors compared between the two stocks.

How does Integer compare to Insulet?

Insulet (NASDAQ:PODD) and Integer (NYSE:ITGR) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends.

Insulet presently has a consensus price target of $233.38, indicating a potential upside of 39.35%. Integer has a consensus price target of $97.00, indicating a potential downside of 3.31%. Given Insulet's stronger consensus rating and higher probable upside, analysts plainly believe Insulet is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insulet	2 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	0 Strong Buy rating(s)	2.68
Integer	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54

99.3% of Integer shares are owned by institutional investors. 0.4% of Insulet shares are owned by insiders. Comparatively, 1.1% of Integer shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Insulet has higher revenue and earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insulet	$2.71B	4.28	$247.10M	$4.30	38.95
Integer	$1.85B	1.84	$102.81M	$4.01	25.02

Insulet has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market. Comparatively, Integer has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market.

In the previous week, Insulet had 32 more articles in the media than Integer. MarketBeat recorded 43 mentions for Insulet and 11 mentions for Integer. Integer's average media sentiment score of 1.49 beat Insulet's score of 0.49 indicating that Integer is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Insulet	13 Very Positive mention(s)	1 Positive mention(s)	27 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Integer	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Insulet has a net margin of 10.44% compared to Integer's net margin of 7.64%. Insulet's return on equity of 26.87% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Insulet	10.44%	26.87%	12.01%
Integer	7.64%	12.83%	6.51%

Summary

Insulet beats Integer on 13 of the 17 factors compared between the two stocks.

How does Integer compare to Globus Medical?

Integer (NYSE:ITGR) and Globus Medical (NYSE:GMED) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

99.3% of Integer shares are owned by institutional investors. Comparatively, 95.2% of Globus Medical shares are owned by institutional investors. 1.1% of Integer shares are owned by company insiders. Comparatively, 18.4% of Globus Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Integer and Integer both had 11 articles in the media. Integer's average media sentiment score of 1.49 beat Globus Medical's score of 1.42 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Globus Medical	10 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Integer has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market. Comparatively, Globus Medical has a beta of 0.95, indicating that its share price is 5% less volatile than the broader market.

Integer presently has a consensus target price of $97.00, indicating a potential downside of 3.31%. Globus Medical has a consensus target price of $102.08, indicating a potential upside of 26.82%. Given Globus Medical's stronger consensus rating and higher possible upside, analysts plainly believe Globus Medical is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54
Globus Medical	0 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.76

Globus Medical has a net margin of 18.92% compared to Integer's net margin of 7.64%. Globus Medical's return on equity of 13.46% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	7.64%	12.83%	6.51%
Globus Medical	18.92%	13.46%	11.65%

Globus Medical has higher revenue and earnings than Integer. Globus Medical is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	1.84	$102.81M	$4.01	25.02
Globus Medical	$2.94B	3.72	$537.87M	$4.30	18.72

Summary

Globus Medical beats Integer on 13 of the 16 factors compared between the two stocks.

Get Integer News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ITGR vs. The Competition

Export

Metric	Integer	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$3.38B	$7.54B	$7.08B	$23.66B
Dividend Yield	N/A	1.30%	2.66%	4.20%
P/E Ratio	25.02	48.08	27.28	31.08
Price / Sales	1.84	96.94	578.34	14.27
Price / Cash	9.59	25.93	49.60	31.92
Price / Book	2.01	7.05	10.13	4.83
Net Income	$102.81M	$162.27M	$3.60B	$1.07B
7 Day Performance	4.01%	0.45%	-0.95%	0.69%
1 Month Performance	10.27%	-3.56%	-3.60%	0.89%
1 Year Performance	-8.21%	4.39%	20.53%	15.67%

Integer Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ITGR Integer	2.5457 of 5 stars	$100.32 +0.9%	$97.00 -3.3%	-7.1%	$3.38B	$1.85B	25.02	11,000
BDSX Biodesix	3.4996 of 5 stars	$22.12 -0.4%	$28.33 +28.1%	+152.2%	$229.12M	$96.10M	N/A	220	Upcoming Earnings
ELV Elevance Health	4.8786 of 5 stars	$373.26 -1.3%	$440.90 +18.1%	+34.8%	$80.41B	$199.13B	16.48	97,100	Positive News
BAX Baxter International	1.3219 of 5 stars	$24.47 +4.8%	$20.27 -17.1%	-14.4%	$12.61B	$11.24B	N/A	37,500	Trending News Upcoming Earnings Analyst Forecast
PODD Insulet	4.6193 of 5 stars	$170.08 +3.1%	$235.25 +38.3%	-42.7%	$11.78B	$2.90B	39.55	5,400	Trending News Upcoming Earnings Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ITGR) was last updated on 7/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Integer (ITGR) Competitors

ITGR vs. BDSX, ELV, BAX, PODD, and GMED

How does Integer compare to Biodesix?

Summary

How does Integer compare to Elevance Health?

Summary

How does Integer compare to Baxter International?

Summary

How does Integer compare to Insulet?

Summary

How does Integer compare to Globus Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ITGR vs. The Competition

Integer Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Integer (ITGR) Competitors

ITGR vs. BDSX, ELV, BAX, PODD, and GMED

How does Integer compare to Biodesix?

Which has more risk & volatility, BDSX or ITGR?

Does the media refer more to BDSX or ITGR?

Is BDSX or ITGR more profitable?

Do analysts prefer BDSX or ITGR?

Do institutionals & insiders hold more shares of BDSX or ITGR?

Which has preferable valuation and earnings, BDSX or ITGR?

Summary

How does Integer compare to Elevance Health?

Do analysts recommend ITGR or ELV?

Which has more risk & volatility, ITGR or ELV?

Which has preferable valuation and earnings, ITGR or ELV?

Do insiders and institutionals believe in ITGR or ELV?

Does the media prefer ITGR or ELV?

Is ITGR or ELV more profitable?

Summary

How does Integer compare to Baxter International?

Do analysts recommend BAX or ITGR?

Which has higher earnings & valuation, BAX or ITGR?

Which has more risk and volatility, BAX or ITGR?

Does the media refer more to BAX or ITGR?

Is BAX or ITGR more profitable?

Do insiders & institutionals hold more shares of BAX or ITGR?

Summary

How does Integer compare to Insulet?

Do analysts rate PODD or ITGR?

Do insiders and institutionals believe in PODD or ITGR?

Which has preferable valuation & earnings, PODD or ITGR?

Which has more risk and volatility, PODD or ITGR?

Does the media favor PODD or ITGR?

Is PODD or ITGR more profitable?

Summary

How does Integer compare to Globus Medical?

Do insiders & institutionals believe in ITGR or GMED?

Does the media favor ITGR or GMED?

Which has more risk and volatility, ITGR or GMED?

Do analysts prefer ITGR or GMED?

Is ITGR or GMED more profitable?

Which has preferable earnings & valuation, ITGR or GMED?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ITGR vs. The Competition

Integer Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools